Tapewire

NYSE · USD

NOC

NORTHROP GRUMMAN CORP /DE/

Export transactions ↓
Tapewire entity
2963
SEC CIK
0001133421
Parsed reports
704

Last 12 months

Inside the activity.

0 purchase rows · 61 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202507
Dec 202501
Jan 202602
Feb 2026029
Mar 202601
Apr 202600
May 2026011
Jun 202600
Jul 202600
Aug 2026010
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 06, 2025 Filed Mar 6, 2025 23:19 UTC
Warden Kathy JDirector · Chair, CEO and President
SaleCommon Stock 3,750 $475.65 $1,783,687.50
Disclosure

SEC source: 0001628280-25-011084 · wk-form4_1741303154.xml · nonDerivative · entry 1

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,852.4

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 1 $479.50 $479.50
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 10

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,073

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 2 $477.39 $954.78
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 9

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,074

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F8 · price: Represents the weighted average sale price of $477.39 rounded to the nearest hundredth. The highest price at which the shares were sold was $477.74 and the lowest price at which the shares were sold was $477.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 4 $476.38 $1,905.52
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 8

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,076

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · price: Represents the weighted average sale price of $476.38 rounded to the nearest hundredth. The highest price at which the shares were sold was $476.49 and the lowest price at which the shares were sold was $476.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 14 $475.19 $6,652.66
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 7

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,080

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: Represents the weighted average sale price of $475.19 rounded to the nearest hundredth. The highest price at which the shares were sold was $475.21 and the lowest price at which the shares were sold was $475.18. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 1 $473.50 $473.50
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 6

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,094

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 3 $471.21 $1,413.63
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 5

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,095

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: Represents the weighted average sale price of $471.21 rounded to the nearest hundredth. The highest price at which the shares were sold was $471.43 and the lowest price at which the shares were sold was $471.09. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 2 $470.90 $941.80
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 4

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,098

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: Represents the weighted average sale price of $470.90 rounded to the nearest hundredth. The highest price at which the shares were sold was $470.92 and the lowest price at which the shares were sold was $470.87. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 1 $469.54 $469.54
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 3

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,100

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 3 $468.10 $1,404.30
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 2

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,101

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: Represents the weighted average sale price of $468.10 rounded to the nearest hundredth. The highest price at which the shares were sold was $468.17 and the lowest price at which the shares were sold was $468.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 20:03 UTC SaleCommon Stock 2 $467.74 $935.48
Disclosure

SEC source: 0001628280-25-010867 · wk-form4_1741291378.xml · nonDerivative · entry 1

WELSH MARK A III · CIK 0001692554 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,104

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: Represents the weighted average sale price of $467.74 rounded to the nearest hundredth. The highest price at which the shares were sold was $467.79 and the lowest price at which the shares were sold was $467.68 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4

Read SEC document
February 28, 2025 Filed Mar 3, 2025 23:06 UTC
Davies Benjamin R.CVP & Pres. Defense Systems
SaleCommon Stock 464 $460.75 $213,788.00
Disclosure

SEC source: 0001628280-25-009537 · wk-form4_1741043169.xml · nonDerivative · entry 1

Davies Benjamin R. · CIK 0002026085 · CVP & Pres. Defense Systems

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 244.72

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2024.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 21:07 UTC
Hardesty Michael ACorp VP, Controller & CAO
SaleCommon Stock 1,931 $453.59 $875,872.64
Disclosure

SEC source: 0001628280-25-008138 · wk-form4_1740604067.xml · nonDerivative · entry 1

Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,715.65

Read SEC document
February 20, 2025 Filed Feb 24, 2025 21:48 UTC
Simpson Kathryn GCorp VP & General Counsel
SaleCommon Stock 1,035 $429.08 $444,097.80
Disclosure

SEC source: 0001628280-25-007396 · wk-form4_1740433678.xml · nonDerivative · entry 1

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 779.43

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2024.

Read SEC document
February 20, 2025 Filed Feb 24, 2025 21:46 UTC
Davies Benjamin R.CVP & Pres. Defense Systems
SaleCommon Stock 192 $429.08 $82,383.36
Disclosure

SEC source: 0001628280-25-007395 · wk-form4_1740433575.xml · nonDerivative · entry 1

Davies Benjamin R. · CIK 0002026085 · CVP & Pres. Defense Systems

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 708.72

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2024.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
Exercise / conversionRestricted Stock Rights · Derivative 468 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · derivative · entry 9

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,084

Underlying: Common Stock · 468 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock

F5 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock

F9 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
Exercise / conversionRestricted Performance Stock Rights · Derivative 1,096.75 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · derivative · entry 8

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,960

Underlying: Common Stock · 1,096.75 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F8 · balance_after: Total amount includes (i) 902 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 3,774 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iii) 4,284 RPSRs granted under the 2024 LITSP on 2/15/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
GrantRestricted Stock Rights · Derivative 1,965 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · derivative · entry 7

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,552

Underlying: Common Stock · 1,965 shares

Expires not disclosed

F5 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock

F5 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock

F6 · derivative.expiration_date: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028.

F7 · balance_after: Total amount includes (i) 468 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 387 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 1,732 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; and (iv) 1,965 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
GrantRestricted Performance Stock Rights · Derivative 4,355.75 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · derivative · entry 6

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,056.75

Underlying: Common Stock · 4,355.75 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F3 · shares: The RPSRs acquired include (i) 71.75 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 4,284 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 1,096.75 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 1,025 RPSRs was previously reported in connection with the grant of the 2022 RPSRs.

F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F4 · balance_after: Total amount includes (i) 1,096.75 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 902 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 3,774 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iv) 4,284 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
SaleCommon Stock 889 $445.35 $395,916.15
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · nonDerivative · entry 5

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,814.43

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2024.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
Tax withholdingCommon Stock 163 $441.36 $71,941.68
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · nonDerivative · entry 4

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,703.43

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
Exercise / conversionCommon Stock 468 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · nonDerivative · entry 3

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,866.43

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
Tax withholdingCommon Stock 366 $441.36 $161,537.76
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · nonDerivative · entry 2

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,398.43

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:18 UTC
Simpson Kathryn GCorp VP & General Counsel
Exercise / conversionCommon Stock 1,096.75 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006864 · wk-form4_1740089922.xml · nonDerivative · entry 1

Simpson Kathryn G · CIK 0001986485 · Corp VP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,764.43

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
Exercise / conversionRestricted Stock Rights · Derivative 11,672 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 8

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,667

Underlying: Common Stock · 11,672 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F8 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
Exercise / conversionRestricted Performance Stock Rights · Derivative 27,350.27 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 7

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,279

Underlying: Common Stock · 27,350.27 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F7 · balance_after: Total amount includes (i) 23,342 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 24,309 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iii) 25,628 RPSRs granted under the 2024 LITSP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
GrantRestricted Stock Rights · Derivative 11,752 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 6

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,339

Underlying: Common Stock · 11,752 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F5 · derivative.expiration_date: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028.

F6 · balance_after: Total amount includes (i) 11,672 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 10,760 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 11,155 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; and (iv) 11,752 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
GrantRestricted Performance Stock Rights · Derivative 27,417.27 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 5

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,629.27

Underlying: Common Stock · 27,417.27 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F2 · shares: The RPSRs acquired include (i) 1,789.27 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 25,628 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 27,350.27 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 25,561 RPSRs was previously reported in connection with the grant of the 2022 RPSRs.

F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F3 · balance_after: Total amount includes (i) 27,350.27 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 23,342 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 24,309 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iv) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
Tax withholdingCommon Stock 4,925 $441.36 $2,173,698.00
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 4

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,602.4

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
Exercise / conversionCommon Stock 11,672 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 3

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,527.4

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
Tax withholdingCommon Stock 12,335 $441.36 $5,444,175.60
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 2

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,855.4

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:19 UTC
Warden Kathy JDirector · Chair, CEO and President
Exercise / conversionCommon Stock 27,350.27 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 1

Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,190.4

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
Exercise / conversionRestricted Stock Rights · Derivative 292 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · derivative · entry 10

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,157

Underlying: Common Stock · 292 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F6 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F10 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
Exercise / conversionRestricted Performance Stock Rights · Derivative 684.8 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · derivative · entry 9

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,864

Underlying: Common Stock · 684.8 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F3 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F3 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F9 · balance_after: Total amount includes (i) 4,376 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 5,133 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iii) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
GrantRestricted Stock Rights · Derivative 2,456 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · derivative · entry 8

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,449

Underlying: Common Stock · 2,456 shares

Expires not disclosed

F6 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F6 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F7 · derivative.expiration_date: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028.

F8 · balance_after: Total amount includes (i) 292 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 2,017 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iIi) 328 RSRs granted under the 2011 LTISP on 12/5/23 that will vest on 12/5/25; (iv) 2,356 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; and (v) 2,456 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
GrantRestricted Performance Stock Rights · Derivative 5,399.8 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · derivative · entry 7

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,548.8

Underlying: Common Stock · 5,399.8 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F4 · shares: The RPSRs acquired include (i) 44.80 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 5,355 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 684.80 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 640 RPSRs was previously reported in connection with the grant of the 2022 RPSRs.

F3 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F3 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F5 · balance_after: Total amount includes (i) 684.80 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 4,376 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 5,133 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iv) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
Tax withholdingCommon Stock 104 $441.36 $45,901.44
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · nonDerivative · entry 4

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,309.91

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
Exercise / conversionCommon Stock 292 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · nonDerivative · entry 3

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,413.91

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
Tax withholdingCommon Stock 229 $441.36 $101,071.44
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · nonDerivative · entry 2

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,121.91

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:17 UTC
ROEDER ROSHAN SCVP & Pres. Mission Systems
Exercise / conversionCommon Stock 684.8 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006862 · wk-form4_1740089867.xml · nonDerivative · entry 1

ROEDER ROSHAN S · CIK 0001950117 · CVP & Pres. Mission Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,350.91

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
Exercise / conversionRestricted Stock Rights · Derivative 2,457 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · derivative · entry 8

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,964

Underlying: Common Stock · 2,457 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F8 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
Exercise / conversionRestricted Performance Stock Rights · Derivative 5,757.67 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · derivative · entry 7

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,157

Underlying: Common Stock · 5,757.67 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F7 · balance_after: Total amount includes (i) 4,669 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 5,133 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iii) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
GrantRestricted Stock Rights · Derivative 2,456 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · derivative · entry 6

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,421

Underlying: Common Stock · 2,456 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F5 · derivative.expiration_date: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028.

F6 · balance_after: Total amount includes (i) 2,457 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 2,152 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 2,356 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; and (iv) 2,456 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
GrantRestricted Performance Stock Rights · Derivative 5,731.67 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · derivative · entry 5

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,914.67

Underlying: Common Stock · 5,731.67 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F2 · shares: The RPSRs acquired include (i) 376.67 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 5,355 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 5,757.67 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 5,381 RPSRs was previously reported in connection with the grant of the 2022 RPSRs.

F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F3 · balance_after: Total amount includes (i) 5,757.67 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 4,669 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 5,133 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iv) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
Tax withholdingCommon Stock 915 $441.36 $403,844.40
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · nonDerivative · entry 4

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,009.595

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
Exercise / conversionCommon Stock 2,457 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · nonDerivative · entry 3

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,924.595

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
Tax withholdingCommon Stock 2,924 $441.36 $1,290,536.64
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · nonDerivative · entry 2

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,467.595

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Jones Thomas HCVP & Pres Aeronautics Systems
Exercise / conversionCommon Stock 5,757.67 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006861 · wk-form4_1740089800.xml · nonDerivative · entry 1

Jones Thomas H · CIK 0001834674 · CVP & Pres Aeronautics Systems

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,391.595

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Hardesty Michael ACorp VP, Controller & CAO
Exercise / conversionRestricted Stock Rights · Derivative 655 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006859 · wk-form4_1740089754.xml · derivative · entry 8

Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,653

Underlying: Common Stock · 655 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

F8 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:16 UTC
Hardesty Michael ACorp VP, Controller & CAO
Exercise / conversionRestricted Performance Stock Rights · Derivative 1,536.52 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006859 · wk-form4_1740089754.xml · derivative · entry 7

Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,600

Underlying: Common Stock · 1,536.52 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F7 · balance_after: Total amount includes (i) 1,167 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 1,208 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iii) 1,225 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.